| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |